Tag Archives: Clinical

Artificial intelligence in intensive care units: University Hospital Freiburg relies on x-cardiac technology in clinical routine

Berlin: Berlin-based x-cardiac GmbH is pleased to announce that Freiburg University Hospital has become the second pilot customer for its AI-based software “x-c-bleeding” for predicting severe bleeding complications after cardiac surgery. With the implementation of “x-c-bleeding”, the University Hospital Freiburg takes another important step towards AI-based medicine. Severe post-operative bleeding and acute renal injury are… Read More »

Essential Reads: A Clinical Guide for the Diagnosis and Treatment of PMDD

In an evidence-based review published in 2012, Laura Wakil, Samantha Meltzer-Brody, and Susan Girdler present a thorough review of premenstrual dysphoric disorder (PMDD), reviewing its diagnosis and treatment options. The information provided is clear and provides an excellent framework for understanding PMDD. In addition, this article includes a section on the association between PMS/PMDD and… Read More »

FDA Clears Most Powerful Clinical MRI

GE Healthcare won FDA clearance for its SIGNA 7.0T MRI scanner, currently the most powerful device available for clinical applications. A high end scanner’s magnetic field typically tops out at 3 Tesla, but the new device goes all the way up to 7 Tesla to provide an unprecedented look at highly detailed anatomy. Certainly intended… Read More »

Clinical Update 2020: Lamotrigine (Lamictal) and Pregnancy

Clinical Update 2020: Lamotrigine (Lamictal) and Pregnancy Maintenance treatment with a mood stabilizer during pregnancy can significantly reduce the risk of relapse in women with bipolar disorder; however, many of the mood stabilizers commonly used in this setting, including lithium and valproic acid, carry some degree of teratogenic risk. In contrast, lamotrigine (Lamictal) appears to… Read More »

Clinical Update 2020: Antipsychotic Medications and Risk of Gestational Diabetes

Given the number of younger women using atypical antipsychotic medications, there is an urgent need for more accurate data regarding the reproductive safety of these medications. One important question is whether these newer antipsychotic medications, which have been associated with an increased risk of metabolic syndrome and diabetes, may increase the risk of gestational diabetes… Read More »